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Abstract
Background: Preterm delivery is the leading cause of neonatal morbidity and mortality. Two-thirds of preterm
deliveries are idiopathic. The initiating molecular mechanisms behind spontaneous preterm delivery are unclear.
Umbilical cord blood DNA samples are an easy source of material to study the neonatal state at birth. DNA
methylation changes can be exploited as markers to identify spontaneous preterm delivery. To identify methylation
differences specific to idiopathic preterm delivery, we assessed genome-wide DNA methylation changes in 24
umbilical cord blood samples (UCB) using the 450 K Illumina methylation array. After quality control, conclusions
were based on 11 term and 11 idiopathic preterm born neonates. The differentially methylated positions (DMPs)
specific for preterm/term delivery, neonatal sex, use of oxytocin and mode of initiation of labor were calculated by
controlling the FDR p value at 0.05.
Results: The analysis identifies 1855 statistically significant DMPs between preterm and term deliveries of which 508
DMPs are also attributable to clinical variables other than preterm versus term delivery.
1347 DMPs are unique to term vs preterm delivery, of which 196 DMPs do not relate to gestational age as such.
Pathway analysis indicated enrichment of genes involved in calcium signalling, myometrial contraction and
relaxation pathways. The 1151 DMPs that correlate with advancing gestational age (p < 0.05) include 161 DMPs that
match with two previously reported studies on UCB methylation.
Additionally, 123 neonatal sex specific DMPs, 97 DMPs specific to the induction of labour and 42 DMPs specific to
the mode of initiation of labor were also identified.
Conclusion: This study identifies 196 DMPs in UCB DNA of neonates which do not relate to gestational age or any
other clinical variable recorded and are specific to idiopathic preterm delivery. Furthermore, 161 DMPs from our study
overlap with previously reported studies of which a subset is also reported to be differentially methylated at 18 years of
age. A DMP on MYL4, encoding myosin light chain 4, is a robust candidate for the identification of idiopathic preterm
labour as it is identified by all 3 independent studies.
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Background
Preterm birth, defined as delivery before 37 weeks of
gestation, has a global prevalence of 9.6 %. It is the lead-
ing cause of neonatal morbidity and mortality and is re-
sponsible for approximately 70 % of all neonatal deaths
and 40 % of childhood neurological morbidities [1, 2].
One third of preterm births are iatrogenic because of
maternal or fetal reasons, usually in relation to maternal
hypertensive disease. Two thirds occur as a consequence
of idiopathic preterm delivery initiated by either spontan-
eous preterm labor (PtLb) with intact membranes or pre-
term premature rupture of membranes (PPROM) [3, 4].
The initiating mechanisms behind the inappropriate
early activation of labor are poorly understood. Known
risk factors include uterine anomalies, multiple gesta-
tions, polyhydramnios, blood loss, infection and previous
preterm birth [3]. There are no early diagnostic or prog-
nostic markers for spontaneous preterm birth.
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The timing of delivery is an intricate play between the
fetus, uterus, decidua and placenta. Fetal growth increas-
ing the tension in the uterine wall, increased oxytocin
and estrogen bioactivity, progesterone withdrawal and
inflammatory decidual activation, all contribute to the
initiation of contractions [3, 5]. For several populations
susceptibility loci influencing preterm birth have been
reported, but until now this has not resulted in the iden-
tification of additional general mechanisms involved in
preterm labor [6–9]. It is currently not known if there
are other fetal properties, apart from fetal growth, that
relate to the premature onset of delivery.
Epigenetics is an important regulatory mechanism
contributing to the control of gene expression. It has
been suggested that epigenetics is involved in idiopathic
preterm delivery in humans [10]. DNA methylation in
myometrium is known to contribute to the functional
progesterone withdrawal associated with labor [11, 12].
The amnion shows significant methylation changes in the
promoter region of the oxytocin receptor gene between
preterm and term labor [13]. Cervical DNA methylation
has also been associated with gestational length [14].
Although a few studies reported the differential DNA
methylation profile of umbilical cord blood (UCB) in re-
lation to preterm delivery, the overall emerging picture
is complicated by variability in mode of delivery, limita-
tions to specific ethnicity, the absence of information on
the progression of labor after initiation of contractions
and the inclusion of patients with hypertensive disease
[15–17].
In the current study, we investigate the genome-wide
methylation profile in UCB from 12 preterm and 12
matched term neonates all born after vaginal delivery
from normotensive pregnancies and identify genes that
could function as leads to establish early diagnostic
markers for idiopathic preterm delivery.
Results
Sample cohort
We selected 24 UCB samples from neonates born after
normotensive singleton pregnancies that presented head-
first and were vaginally delivered (see Additional file 1:
Table S1). Gestational age at delivery ranged from 26 weeks
and 3 days to 41 weeks and 4 days; delivery before 37 weeks
of gestation was considered preterm. Two samples had to
be excluded because of reasons described extensively
below resulting in the analysis of 22 samples. Neonatal
birth percentile specific for parity, neonatal sex and gesta-
tional age was calculated based on the Dutch neonatal
growth charts (www.perinatreg.nl). Apart from the gesta-
tional age of delivery, neonatal weight and treatment with
antenatal glucocorticoids, all characteristics intrinsic to the
gestational age at birth, there are no clinical differences
between groups (see Table 1).
Neonatal sex chromosomal variations detected by DNA
methylation profiling of umbilical cord blood
The Illumina 450 K BeadChip array was used to deter-
mine methylation status in our UCB cohort. As an ini-
tial check for sample integrity, the 24 samples of the
original dataset were grouped as males or females based
on their phenotype at birth (male: n = 12; female: n = 12;
Additional file 1: Table S1) Multi-dimensional scaling
(MDS) analysis was performed on raw intensity signals as
a quality control step using the ChAMP package, which
resulted in a male neonate born at term (T4) clustering
together with the females in our dataset (Fig. 1a). Levels
of probe intensity suggested that this sample gained
one X chromosome. This finding was validated on
DNA isolated from placenta tissue from this pregnancy
that was available through our PANDA biobank project
using quantitative fluorescent polymerase chain reac-
tion (QF-PCR) (see Fig. 1b). The QF-PCR signal pattern
for markers DXS6803, HPRT, and TAF9 (regions Xq21.31,
Xq26.2 and Xq21.1 respectively) are consistent with the
presence of 2 X chromosomes. The signal from SRY
(Yp11.31) marker confirms the presence of a Y chromo-
some. The signal pattern for AMEL (Xp22.22/Yp11.2) is
consistent with two X chromosomes and one Y chromo-
some. The copy number analysis for chromosome X and
Y showed evidence of an XXY chromosomal pattern con-
cordant with Klinefelter syndrome. This sample was ex-
cluded from further methylation analysis (Additional file
1: Table S1).
Genome-wide methylation differences in umbilical cord
blood DNA between preterm and term infants at birth
The array quality metrics package [18] was used to
check for quality of the array data and we identified one
outlying sample with signal intensity strongly deviating
from all other samples. This sample (PT9) was excluded
from further analysis (Additional file 1: Table S1).
Differential methylation analysis was performed on 11
preterm and 11 term DNA samples isolated from UCB.
We identified 1855 statistically significant differentially
methylated positions (DMPs) (FDR p < 0.05), of which,
1347 DMPs can be solely attributed to methylation dif-
ferences between infants born preterm and term. For the
comparisons male vs female, no-stimulation vs stimula-
tion with oxytocin and initiation with PtLb vs PPROM,
the number of DMPs unique for the comparison groups
are 123, 97 and 42 respectively (Fig. 2a, Additional file 2:
Table S2, Additional file 4: Table S4a, Additional file 5:
Table S5a, Additional file 6). The remaining 246 DMPs
were shared by 2 or more groups (Fig. 2a, Additional file
7: Table S7).
For all comparison groups 35-40 % of DMPs are present
in gene bodies (Fig. 2b) reflecting the distribution of
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probes available on the array, of which 33 % are present in
gene bodies.
Correlation of unique term vs preterm DMPs with clinical
variables
A hierarchical clustering analysis was performed, in
order to identify the clinical variables that associated
with the 1347 DMPs identified in the term vs preterm
group (Fig. 3a). The DMPs group into 3 main clusters
based on gestational age; strictly preterm (26+3 till 31+3),
intermediate (29+6 till 38+4) and term (38+3 till 41+4)
(Fig. 3b). 1-way ANOVA with 2 degrees of freedom
shows that the median gravidity of the intermediate
group is significantly higher when compared to the
strictly preterm group (adjusted p = 0.04). A Pearson
correlation test was used to identify the degree of correl-
ation of every DMP with gestational age controlling the
FDR at 0.05. Of the total 1347 DMPs, 1151 DMPs cor-
relate significantly with gestational age of which 762
DMPs with a positive and 389 DMPs with a negative
correlation to gestational age (Fig. 3c). The DMPs lo-
cated on gene regions with the highest correlation of
gestational age with a negative correlation are NCOR2,
DNAJC17, PYCR2, ATP6V0A1, RARA and FBLN7 and
DMPs with a positive correlation are IGF2BP1, OTOF,
ATP2B2, CES3 and MYH7B. The methylation trend of
the majority of gestational age related DMPs increases
with advancing gestation and within this set are 3 DMPs
localising to the ESR1 gene (see Additional file 2: Table
S2, colour shading reflecting Fig. 3c).
The remaining 196 DMPs that do not correlate with
gestational age reflect the systematic difference between
both groups. DMPs on KIAA0513, UBE21 and AP3D1
have the highest absolute difference between groups
with a p value <0.05 (see Additional file 3: Table S3a).
Pathway analysis
Pathway analysis was performed for all the DMPs identified
in each individual comparison group. The gene symbols of
the observed DMPs were imported into Web-Gestalt [19,
20] and wiki pathway enrichment analysis was performed
with FDR at 0.05. The 42 DMPs specific for the comparison
of initiation with PtLb vs PPROM could not be assigned to
specific pathways. Among the top enriched pathways in the
term vs preterm UCB group, are MAPK signalling, myome-
trial relaxation and contraction pathway and TGF beta
signalling pathway (p < 0.05) (Additional file 3: Table S3).
The pathway involving calcium regulation in cardiac cell
is observed in all 3 comparison groups. Both the term vs
preterm and the male vs female comparisons showed an
enrichment in myometrial relaxation and contraction
pathway, insulin signalling and signalling pathways in glio-
blastoma. Although the pathways indicated are the same,
the genes allocated to them are different, with the excep-
tion of SLC8A1.
Linkage to other studies
To complement our approach of methylation analysis
with relevance to preterm birth we compared DMPs
identified in our study to DMPs identified by two other
studies on cord blood methylation using the Illumina
BeadChip technology (Fig. 4). In total, 161 of the 1347
DMPs that are uniquely assigned to the term versus pre-
term comparison have been reported previously [15, 17].
We identified DMPs on ESR1, TMEM184A and GP1BB
that have been previously associated with gestational age
Table 1 Maternal and fetal characteristics of the UCB study cohort
Clinical parameter Preterm delivery Term delivery P-value
Number of samples 11 11 1**
Nulliparous 5 (50 %) 6 (55 %) 0.99**
Received antenatal glucocorticoids 9 (82 %) 0 (0 %) 0.0002**
Parturition initiated with spontaneous labor 7 (64 %) 7 (64 %) 1**
Parturition initiated with spontaneous rupture of membranes 4 (36 %) 4 (36 %) 1**
Labor induced or stimulated with oxytocin 5 (45 %) 7 (64 %) 0.67**
Mean gestational age at delivery in weeks + days (range) 29+6 (26+3 – 36+4) 39+6 (38+0 - 41+4) 3.83E-07*
Male neonate 5 (45 %) 6 (55 %) 0.99**
Neonatal weight (g) 1550 (990–2615) 3320 (2525–4215) 7.85E-07*
Neonatal birth weight percentile <10 0 (0 %) 3 (9.09 %) 0.21**
Maternal age 28 (19–35) 28 (19–36) 0.51*
Data are represented as numbers (%) median (range)
Abbreviations: n.s. not significant
P-values were calculated by unpaired student’s T-test* and Fisher’s exact test** as applicable
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in the Schroeder study [15]. DMPs in 157 genes, includ-
ing those on IGF2BP1, ADORA2A and GABBR1, have
been reported by Cruickshank study [17]. A single DMP
on the gene encoding myosin light chain 4 (MYL4), in
the Transcription start site 200 (TSS200) or 5′Untrans-
lated region (5′UTR) depending on the definition of the
5′ prime end of the transcript, is identified by all 3 stud-
ies. The current study confirms 32 of the total 109
DMPs that were differentially methylated at birth and
18 years of age originally identified in the Cruikshank
study. These 32 DMPs correspond to 17 genes (Fig. 4).
The 196 DMPs in the current UCB study that show
no correlation with gestational age do not overlap with
the 29 DMPs that associate with preterm birth adjusted
for gestational age reported previously. Of these 29, the
DMP cg03706951 in our study shows a negative correl-
ation with gestational age. The other 28 are not identi-
fied as DMPs in the current study [16].
Fig. 1 Neonatal sex chromosomal variations detected through quality control of umbilical cord blood Illumina 450 K data. a Multi-dimensional
scaling (MDS) plot on neonatal sex on the top 1000 methylation variable positions between male (in red) and female (in green) samples;
T4-Klinefilter neonate. b Validation of the X-chromosomal gain of neonate T4 by QF-PCR supporting the diagnosis of Klinefelter Syndrome:
Markers DXS6803 (Xq21.31), HPRT (Xq26.2), TAF9L (Xq21.1), DXS1187 (Xq26.2) are specific for the X chromosome. Markers SRY (Yp11.31) and AMEL
(Xp22.22)/ (Yp11.2) are specific for the Y chromosome
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UCB Differentially Methylated Regions (DMRs) between
term and preterm neonates
With a FDR at 0.05, we identified 20 differentially meth-
ylated regions (DMRs) between preterm and term neo-
nates; 2 non-annotated regions, a non-coding RNA
(gene ID: 100131213) and 17 genes (Table 2). Out of the
20, 6 of the identified DMRs are located on chromosome
6. The genes with DMRs were queried for GO biological
processes. The top 4 DMRs are located on genes in-
volved in neuronal development such as PPT2, GABBR1,
PLEKHB1 and induction of immunity such as ZC3H12D
[21]. Interestingly ADORA2A, a gene involved in vascu-
lar smooth muscle contraction pathway, was identified
as a DMR covering 4 DMPs in this analysis (Fig. 5).
Discussion
DNA methylation plays an important role in gene regu-
lation and in the etiology of complex diseases [22]. UCB
DNA is an easily available source and relevant for the
fetal state at the moment of birth. The umbilical cord
blood DNA comprises of a mixed population of all types
of blood cells and other tissue cells that have entered
the circulation. However, the extent to which the DNA
methylation profile of UCB reflects those in other tissues
is still a matter of debate. Fetal DNA is detectable in the
maternal circulation early in pregnancy facilitating non-
invasive prenatal testing [23, 24]. Recent developments
have shown that the fetal methylome is also accessible
from maternal plasma, thus enhancing the opportunity
to determine fetal epigenetic markers in the maternal
circulation [25].
In the current study, we characterize the methylation
profile in UCB DNA specific to spontaneous preterm
delivery, neonatal sex, use of oxytocin and mode of ini-
tiation of labor using the Illumina 450 K bead chip.
This technical approach is also evidently able to reveal
Fig. 2 Differentially methylated positions (DMPs) in umbilical cord blood DNA between preterm and term infants. a Venn Diagram depicting
the differentially methylated CpG sites within each of the four comparison groups (term versus preterm delivery, male versus female neonates,
vaginal delivery with contraction stimulated by oxytocin versus not stimulated and whether the process of delivery initiated with PtLb versus
PPROM as well as overlap between groups and subgroups). False Discovery Rate (BH: 0.05). b Illustration of the distribution of DMPs over gene
regions for all comparison groups. The TSS200: region 200 base pairs within the transcription start site (TSS); TSS: region 1500 base pairs within
the TSS excluding the TSS 200 region; UTR: untranslated region as present in the mRNA molecule respectively 5′ of the transcription start site
(5′UTR) and 3′ of the termination signal (3′UTR); Body: coding and non-coding regions from the TSS until the termination codon; IGR:
intergenic region
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copy number aberrations, as we encountered a 47, XXY
neonate in our sample cohort.
There is evidence suggesting gender-specific differ-
ences to the susceptibility and progression of some dis-
eases [26–28]. Some studies have shown that preterm
born females have a better survival rate and neurological
outcome compared to preterm males [29–32]. There is
no functional data proving epigenetics as causal to gen-
der differences but the current study indicated some pu-
tative associations. We identified 123 autosomal DMPs
that differ between males and females irrespective of the
preterm/term status. Within this group are DMPs lo-
cated on PRKCZ, GBE1 and GYG. PRKCZ in cord blood
T cells has been associated with allergy risk in infants
and it has been reported that gender differences affect
susceptibility to the development of hypersensitivity re-
actions [33, 34]. The PRKCZ gene has also been linked
to development of bipolar disorder [35] in line with the
increased risk of psychiatric illness such as bipolar dis-
order in males compared to females [36, 37].
Similarly we also established DMPs in certain CpG
sites specific to oxytocin usage to induce or stimulate
labor. Some of the DMPs in the oxytocin vs no-oxytocin
group are CACNA1D, ADCY9 and ITGA3. According to
KEGG pathways both CACNA1D and ADCY9 are linked
to the oxytocin signalling pathway. In-vivo studies show
that α3β1 integrin (ITGA3) mediated signalling contrib-
utes to the control of amplitude and duration of contrac-
tions in response to oxytocin in mammary myoepithelial
cells [38].
The number of DMPs specific to spontaneous contrac-
tions vs spontaneous rupture of membranes comparison
is too small to perform pathway analysis.
The majority of methylation differences in our study
cohort are between preterm versus term pregnancies.
The 1347 DMPs solely attributable to term versus
Fig. 3 Correlation of birth DMPs with gestational age. Panel a Heat map illustration of the clustering of the birth DMPs with gestational age.
Average linkage clustering was performed on beta values based on the correlation distance between the preterm and term group. PT1-PT12:
Preterm and T1-T12: Term umbilical cord blood DNA. Panel b Clinical characteristics of the study cohort on the left with scaling on the right and
colors reflecting the clusters on the top of panel A. Panel c Pearson correlation(r) with gestational age. Black bars indicate significant correlation
(FDR p < 0.05)
Fernando et al. BMC Genomics  (2015) 16:736 Page 6 of 12
Fig. 4 Comparison of DMPs with other study cohorts. Venn diagram with large circles reflecting the different study cohorts showing the number
of individual and shared DMPs between studies. Green shading reflects all DMPs were the level of methylation correlates with gestational age in
the current study. Smaller inner circle represents 109 DMPs that were observed as differentially methylated both at birth and at 18 years of age
originally identified in the Cruikshank study. The current study confirms 32 of them (listed on the right)
Table 2 Gene annotations of differentially methylated regions in UCB DNA from term and preterm born neonates
Gene ID Gene symbol Number of DMPs Adjusted p value Chromosomal location DMR start position DMR end position
9374 PPT2 16 1,78E-12 6p 32120761 32121161
780 DDR1 13 9,46E-06 6p 30853990 30854352
2550 GABBR1 10 4,15E-08 6p 29599012 29599538
58473 PLEKHB1 8 7,08E-09 11q 73356997 73357675
340152 ZC3H12D 8 1,13E-06 6q 149805798 149806410
57224 NHSL1 7 2,21E-07 6q 138866338 138867573
23007 PLCH1 6 3,45E-07 3q 155421691 155422249
3200 HOXA3 5 7,80E-05 7p 27153536 27153782
79899 PRR5L 5 2,08E-07 11p 36422098 36422894
135 ADORA2A 4 1,68E-05 22q 24823473 24823635
3141 HLCS 4 1,46E-05 21q 38362713 38362783
2247 FGF2 3 1,52E-06 4q 123747468 123747623
51199 NIN 3 1,25E-06 14q 51296493 51296731
5696 PSMB8 3 6,23E-07 6p 32812868 32813030
56963 RGMA 3 9,13E-07 15q 93617020 93617110
10418 SPON1 3 1,83E-07 11p 13983766 13983811
202915 TMEM184A 3 1,95E-06 7p 1595968 1596132
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preterm birth were mainly observed in gene bodies,
intergenic regions and within 1500 basepairs of the
transcription start site, reflecting the number of probes
present in these regions. About 85 % of the 1347 DMPs
observed in UCB of neonates born term vs preterm
have a clear relation with advancing gestational age.
This has been reported before and is assumed to reflect
the haematological changes as leucocyte content, nucle-
ated reticulocyte content and maturation of red blood
cells, all of which strongly correlate with gestational age
[39–42]. In the current cohort gestational ages range
from 26+3 to 41+4 weeks. Hierarchical clustering of the
1347 DMPs separates early preterm from term deliver-
ies and identifies an intermediate gestational age group
(29+6 – 38+4) with a statistically significant higher gra-
vidity. The remaining 196 DMPs represent which do
not correlate with gestational age represent systematic
differences between the preterm and term born neo-
nates and have not been reported previously in relation
to preterm delivery. A study interrogating methylation
patterns in UCB DNA from African-Americans identified
29 CpG sites associated with preterm birth adjusted for
gestational age. None of those were corroborated by the
current study [16]. Wiki pathway analysis and gene
enrichment of our set of 196 DMPs shows calcium and
TGF beta signalling, myometrial contraction and relax-
ation pathways and the corticotrophin releasing hor-
mone pathway. It is well established that calcium
signalling is crucial in the human myometrium for initi-
ation of labor [43]. The genes which are represented in
the myometrial contraction and relaxation pathways
are sodium and calcium exchanger SLC8A1, which also
plays a role in cardiomyocyte contractions, chemokine re-
ceptor CXCR7, guanine nucleotide binding protein GNG7
Fig. 5 The most significant differentially methylated regions (DMRs) between cord blood of preterm and term infants at birth. Individual
differentially methylated positions are listed on the outside of the circle with the radius of the circle corresponding to the level of methylation of
each individual sample for each individual patient. The circle center has beta level zero. The radius of the figure corresponds to beta value with
the center as beta value zero. Dotted lines represent beta values of preterm infants with every line corresponding to an individual preterm
neonate. The solid lines represent beta values of term infants
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and transmembrane signalling enzyme phospholipase C
PLCG2 respectively. Further research will have to deter-
mine if they are putative foetal biomarkers for idiopathic
preterm delivery that can be analysed from the maternal
circulation.
Ideally high-thoughput data from clinical samples need
to be validated either by additional experiments or com-
parative validation to other studies. The limitation of the
current study is that we have not experimentally vali-
dated this finding. However, we have approached this
issue with detailed comparison of previously published
independent studies on UCB methylation. There have
been 3 previous reports on DNA methylation profiles in
UCB analysed with respect to gestational age at delivery
using the Illumina platform [15–17]. The study by
Schroeder et al. analysed 453 UCB samples with gestational
age ranging from 32 to 43 weeks of gestation on a 27 K
platform. Results were adjusted for a number of clinical
variables including neonatal sex and parity and they
showed that associations were independent of the method
of delivery or induction of labor. The study by Cruickshank
et al., interrogated both UCB and blood at 18 years of age
of 12 preterm (25 to 30 weeks of gestation) and 12 term
(36–42 weeks of gestation) born neonates using the 450 K
platform. Two thirds of the mothers did not experience
labor. For both these studies gravidity was not reported.
The 161 DMPs which overlap between our study and
the above mentioned studies provide increased evi-
dence of presence of these methylation differences in
UCB of preterm and term infants at birth. The overlap-
ping DMPs on ESR1 and MYL4 are of interest in the
context of preterm delivery. Increased ESR1 (estrogen
receptor) gene expression in the myometrium is triggered
by functional progesterone withdrawal and results in in-
creased estrogen bioactivity, an important contributor to
the transition from myometrial quiescence to synchro-
nised contractions [44, 45]. As all our neonates were deliv-
ered vaginally, we cannot exclude the fact that labor is
associated with the differential methylation of the ESR1
gene. However, based on the study of Schroeder which
also included samples from neonates delivered by caesar-
ean section, this seems unlikely.
MYL4 encodes myosin light chain 4 that is essential to
the myometrial contraction pathway. MYL4 expression
in mice myometrium is downregulated over two-fold
during quiescence indicating an active role in the pro-
gression to myometrial contractions [46].
A single DMP (cg19817652) on C17orf98 identified
by the Cruickshank study as relating to gestational age
is uniquely attributable to neonatal sex in our study.
The 32 overlapping DMPs with Cruickshank study
which has been experimentally validated to be present
at 18 years of age is of significance due to the long-
term consequence of preterm birth.
DMR analysis identifies 20 significant differentially
methylated regions. The most significant DMR is located
on the PPT2 gene on chromosome 6p21.3 and covers 16
DMPs. PPT2 is located on the major histocompatibility
locus (MHC-III) and its deficiency in homozygous knock
out mice causes a neurodegenerative disorder [47]. There
are 2 other DMRs present on 6p21.3 corresponding to
DDR1 with 13DMPs and PSMB8 with 3DMPs. ZC3H12D
activates TLR signalling in macrophages and plays a role
in immunity and inflammatory diseases. The inflamma-
tory pathway is a well-established important contributor
to the initiation of synchronised myometrial contractions
and interestingly the differential methylation of ZC3H12D
has been shown to persist until at least the age of 18 years
[48]. The ADORA2A encodes the adenosine A2a receptor,
a member of the G-protein coupled receptor superfamily.
Interleukin-1b activates myometrial inflammation and is
able to up regulate ADORA2A expression >20 fold in pri-
mary culture of pregnant human uterine myocytes [49].
ADORA2A, also reported by the Cruickshank study,
shows a relative increased methylation status in UCB
DNA of neonates born after idiopathic preterm labor.
Comparing the methylation and gene expression pro-
files of myometrium, placenta and umbilical cord blood
of preterm and term deliveries could shed more light on
the functional relevance of the methylation changes ob-
served in the cord blood DNA.
Conclusion
This study identifies 1347 methylation changes in umbil-
ical cord blood specific to idiopathic preterm delivery.
The approach to methylation analysis in this study also
delineates methylation changes specific to neonatal sex
giving more insight into sex-specific autosomal methyla-
tion differences at birth enhancing the understanding of
gender specific susceptibility to a specific disease.
In addition, the identification of 161 DMPs which
overlap with other studies offer supportive evidence of
robust methylation differences in UCB between preterm
and term infants. Meta-analysis of raw data sets of these
independent studies combined with detailed information
on clinical data will provide a more robust set of DMPs




From the Preeclampsia And Non-preeclampsia Database
(PANDA) project we used placenta tissue and umbilical
cord genomic DNA with clinical data on maternal health,
the course of pregnancy and pregnancy outcome with in-
formed consent, approved by the ethics committee of the
Academic Medical Center Hospital of the University of
the Amsterdam.
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We selected 24 umbilical cord blood (UCB) samples
from vaginal deliveries of normotensive singleton preg-
nancies where the live born neonate presented head first
and the membranes ruptured spontaneously, either be-
fore or after the start of contractions. Pregnancies with
maternal diabetes, hyper- or hypothyroidism, preeclamp-
sia, HELLP syndrome, congenital heart disease, or intra-
hepatic cholestasis of pregnancy, intra-uterine growth
retardation, fetal distress or any kind of infection were
excluded. We selected UCB from 12 neonates deliv-
ered <37 weeks of gestation and they were matched
to 12 neonates delivered ≥ 37 weeks of gestation with
respect to parity, maternal age, use of oxytocin, initi-
ation of parturition with spontaneous labor or rupture
of membranes and neonates small for gestational age.
UCB was collected in EDTA tubes and processed by
Gentra Autopure LS98™ system (Gentra Systems). Table 1
illustrates the maternal and fetal characteristics of the cord
blood study cohort (Additional clinical data in Additional
file 1: Table S1).
Sample preparation and methylation assay
For each sample, 1ug of genomic DNA was bisulphite
converted using the EZ-DNA methylation kit (Zymo
Research, D5001). The bisulphite converted DNA was
subjected to whole genome amplification, fragmentation
followed by hybridization on Infinium Illumina 450 K
BeadChip array and Cy3 or Cy5 signal intensities were
generated using Illumina iScan.
Quantitative fluorescence-PCR analysis
DNA was isolated from a placenta biopsy using the
MagnaPureLC DNA isolation kit II (Roche). For QF-PCR
aneuploidy screening the QST*Rplus V2 kit (Elucigene
Diagnostics, AN0PLB2) was used according to the manu-
facturer’s instructions. The amplified sample was analyzed
with the ABI 3500 (Applied Biosystems, Foster City,
California, USA). Interpretation of results was per-
formed using guidelines from the manual, the 2012
ACC/CMGS ‘QF-PCR for the diagnosis of aneuploidy
best practice guidelines’ V3.01, 22 and the CCMG ‘Prac-
tice Guidelines for Prenatal QF-PCR’.
Initial data analysis
The array quality metrics package was used to check for
outliers based on array quality that were subsequently
excluded from further analysis [18]. Raw data files con-
taining the methylation intensities were imported into
the ChAMP package [50]. Additional quality control was
performed using ChAMP, and probes with a detection
p-value less than p < 0.01 were filtered out and used for
the analysis scores. The X and Y chromosome methylation
levels in UCB were checked against gender of the neonate
before they were removed from the analysis altogether.
One sample from the preterm group (PT9) was identified
as an outlier based on the distance between arrays and in-
tensity distributions. This sample was excluded from the
dataset before normalization. The Beta-mixture quantile
normalization (BMIQ) method was used to normalize the
dataset and to correct for the Illumina assay-II signal bias
within the Illumina 450 K BeadChip [50]. To avoid methy-
lation bias due to cross hybridizing probes, 29,233 probes
that were previously reported to cross hybridize were re-
moved from the dataset [51]. After the quality control
steps, differential methylation analysis was performed with
the remaining 443,190 probes.
Statistical testing
Linear regression modelling algorithms from the LIMMA
package [52] were used to construct linear models for
each comparison group which include neonatal sex, type
of parturition initiation and induction or co-stimulation
with oxytocin. Samples were assigned into 4 comparison
groups based on 1) preterm or term status 2) neonatal
sex: male or female 3) whether oxytocin was administered
at any time before delivery 4) whether parturition initiated
with PtLb or PPROM. Models were constructed by setting
the M value (log transformed beta value) as outcome and
the attributed group phenotype as independent variable
for each group. The decideTest function was used for
multiple testing across all groups. The differentially meth-
ylated positions (DMPs) were called based on the p value
generated by multiple testing after a false discovery rate
correction (FDR) according to Benjamini and Hochberg
p < 0.05. Gene region information was obtained from
the Illumina manifest file version 1.2. After identifying
the 1347 DMPs that were exclusive to the preterm vs.
term comparison group they were further used to de-
fine differentially methylated regions (DMRs) and per-
form pathway analysis.
Differentially methylated regions
DMRs were calculated using the probe lasso function
of the ChAMP package [50]. A gene region was called
DMR if it had a minimum of 3 or more significant
probes after adjusting for FDR (p < 0.05) and a neigh-
bouring DMR is separated by a distance of maximum
1000 base pairs.
Pathway analysis
The DMPs for each comparison group were narrowed
down to their gene names and imported into Web-
Gestalt for wiki-pathway analysis [19, 20] A hypergeo-
metric statistical testing was performed and a p value
was generated after FDR correction (Benjamini and
Hochberg) p = 0.05.
Fernando et al. BMC Genomics  (2015) 16:736 Page 10 of 12
Availability of supporting data
The methylation data discussed in this publication have
been deposited in NCBI’s Gene Expression Omnibus [53]




Additional file 1: Patient data. (XLS 104 kb)
Additional file 2: DMPs correlating to gestational age (refers to
Fig. 3c). (XLSX 140 kb)
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Additional file 4: a. Systematic differences (DMPs) Female vs Male
neonates. b. Females vs Males- wikipathways. (ZIP 30 kb)
Additional file 5: a. Systematic differences (DMPs) Oxcytocin use. b.
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Additional file 7: DMPs shared between groups. (XLS 155 kb)
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